Mohammed S Abusamaan
Overview
Explore the profile of Mohammed S Abusamaan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanbour S, Zale A, Shim J, Abusamaan M, Mathioudakis N
Endocr Pract
. 2025 Jan;
PMID: 39884508
Objective: To evaluate the efficacy of daily insulin dose increases in managing inpatient hyperglycemia. Methods: Retrospective study of patients discharged from 2 urban academic medical centers and 3 large suburban...
2.
Bhat S, Al-Hajri N, Kanbour S, Ahmadzada M, Borovoy A, Abusamaan M, et al.
Can J Diabetes
. 2024 Sep;
48(8):517-523.e2.
PMID: 39260687
Objective: Our aim in this study was to determine whether there are differences in glycemia during wound and wound-free states among individuals with diabetes at a multidisciplinary diabetic foot and...
3.
Abusamaan M, Ballreich J, Dobs A, Kane B, Maruthur N, McGready J, et al.
Trials
. 2024 May;
25(1):325.
PMID: 38755706
Background: Prediabetes is a highly prevalent condition that heralds an increased risk of progression to type 2 diabetes, along with associated microvascular and macrovascular complications. The Diabetes Prevention Program (DPP)...
4.
Liu T, Shpigel J, Khan F, Smith K, Prichett L, Channa R, et al.
JAMA Netw Open
. 2024 Mar;
7(3):e240728.
PMID: 38446483
Importance: Diabetic retinopathy (DR) is a complication of diabetes that can lead to vision loss. Outcomes of continuous glucose monitoring (CGM) and insulin pump use in DR are not well...
5.
Wallam S, Abusamaan M, Clarke W, Mathioudakis N
Clin Diabetes
. 2023 Apr;
41(2):208-219.
PMID: 37092143
In this retrospective analysis, we explored the correlation between measured average glucose (mAG) and A1C-estimated average glucose (eAG) in hospitalized patients with diabetes and identified factors associated with discordant mAG...
6.
Zale A, Abusamaan M, McGready J, Mathioudakis N
JMIR Form Res
. 2023 Jan;
7:e41577.
PMID: 36719713
Background: Continuous glucose monitors have shown great promise in improving outpatient blood glucose (BG) control; however, continuous glucose monitors are not routinely used in hospitals, and glucose management is driven...
7.
Kanbour S, Jones M, Abusamaan M, Nass C, Everett E, Wolf R, et al.
Diabetes Care
. 2022 Nov;
46(1):56-64.
PMID: 36378855
Objective: Recent studies highlight racial disparities in insulin pump (PUMP) and continuous glucose monitor (CGM) use in children and adolescents with type 1 diabetes (T1D). This study explored racial disparities...
8.
Kanbour S, Yenokyan G, Snyder R, Abusamaan M, Mathioudakis N
Endocr Pract
. 2022 Oct;
28(12):1232-1236.
PMID: 36183992
Objective: Managing hospitalized patients on ambulatory U-500 insulin is challenging because of limited guidance on how to safely adjust insulin doses during admission. We sought to evaluate glycemic outcomes in...
9.
Khan S, Shields S, Abusamaan M, Mathioudakis N
J Diabetes Complications
. 2022 Sep;
36(10):108305.
PMID: 36108545
Aim: Inpatient dysglycemia has been linked to short-term mortality, but longer-term mortality data are lacking. Our aim was to evaluate the association between inpatient dysglycemia and one-year mortality risk. Methods:...
10.
Husni H, Abusamaan M, Dinparastisaleh R, Sokoll L, Salvatori R, Hamrahian A
Front Endocrinol (Lausanne)
. 2022 Sep;
13:978238.
PMID: 36060940
Purpose: There has been debate regarding the appropriate cortisol cutoff during the cosyntropin stimulation test (CST) when newer cortisol assays are used. We aimed to evaluate the proper cortisol values...